NorthLinks Bio
United States, Boston, Massachusetts
About NorthLinks Bio
NorthLinks Bio is a clinical-stage biopharmaceutical company developing broad-spectrum antiviral prophylactics for respiratory viruses. Its lead candidate, HEX17, is a self-administered intranasal spray engineered as a multivalent carbohydrate-binding module that masks host receptors to block viral entry at the point of infection, with demonstrated protection against influenza in a Phase 2 human challenge study. The company was established through RA Capital's Raven incubator around an asset originating from UK-based Pneumagen.
Latest Funding
Series AAnnounced 2026-06-23
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
2 signals · where the capital is going
Build out the clinical-stage team, including CMC and manufacturing leadership, as the company progresses its antiviral program through clinical development.
builtin.com
+1 more capital deployment signal · confidence ratings · source articles
Sign up freeIn the news
Selling to NorthLinks Bio? You're in the right place.
Knowing they raised is the start. The edge is what's attached to NorthLinks Bio.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Ask AI
What is the unique value proposition of NorthLinks Bio, and who are their main competitors?
Sign up free to ask AI about NorthLinks Bio
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
RA Capital Management
Lead investor · Series A
Tech Stack
jsDelivr
Lightbox
HSTS
Contacts
Sarah M.
Head of Sales
Sample preview. Sign up free to see real contacts
Key Highlights
AI InsightsRound led by RA Capital Management; NorthLinks Bio was built through RA Capital's Raven incubator to advance the antiviral asset.
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to NorthLinks Bio
Selling to NorthLinks Bio? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to NorthLinks Bio.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.